2674-0869

Frontiers in Drug Safety and Regulation

Frontiers Media SA

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 115 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact115 DOIs
2

Add abstracts to 18 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact18 DOIs
3

Deposit reference lists for 3 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact3 DOIs

DOIs for this ISSN

Showing the top 5 of 115 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 A New Era of Pharmacovigilance: Future Challenges and Opport… (10.3389/fdsfr.2022.866898)
Abstract ORCID
88.91 59
2 Conducting and interpreting disproportionality analyses deri… (10.3389/fdsfr.2023.1323057)
ORCID
55.37 163
3 Moving to a Personalized Approach in Respiratory Medicine. F… (10.3389/fdsfr.2021.752581)
Abstract ORCID
42.25 6
4 Digital Therapeutics in Perspective: From Regulatory Challen… (10.3389/fdsfr.2022.900946)
ORCID
39.21 36
5 Current Status and Future Challenges in the Treatment of Rhe… (10.3389/fdsfr.2022.881556)
Abstract ORCID
38.91 5
6 Rethinking drug safety signal detection and causality assess… (10.3389/fdsfr.2025.1678074)
Abstract ORCID
38.91 5
7 Specialty grand challenge editorial innovative approaches fo… (10.3389/fdsfr.2023.1187070)
Abstract ORCID
34.95 4
8 Aspects to consider in causality assessment of safety signal… (10.3389/fdsfr.2023.1193413)
ORCID
34.51 23
9 Mucoadhesive polymers in substance-based medical devices: fu… (10.3389/fdsfr.2023.1227763)
ORCID
34.51 23
10 Deprescribing as a strategy for improving safety of medicine… (10.3389/fdsfr.2022.1011701)
ORCID
33.56 21
11 Artificial intelligence for optimizing benefits and minimizi… (10.3389/fdsfr.2024.1356405)
ORCID
30.76 16
12 Editorial: AI/ML in pharmacovigilance and pharmacoepidemiolo… (10.3389/fdsfr.2024.1517365)
Abstract ORCID
30.10 3
13 Towards a European harmonization of health technology assess… (10.3389/fdsfr.2022.970661)
ORCID
27.85 12
14 Menstrual disorders following COVID-19 vaccination: a review… (10.3389/fdsfr.2024.1338466)
ORCID
27.85 12
15 Assessing the performance of large language models in litera… (10.3389/fdsfr.2024.1379260)
ORCID
27.85 12
16 An industry perspective on the use of machine learning in dr… (10.3389/fdsfr.2023.1110498)
ORCID
26.98 11
17 Federated learning: a privacy-preserving approach to data-ce… (10.3389/fdsfr.2025.1579922)
ORCID
26.98 11
18 Increased Confidence in Deduplication of Drug Safety Reports… (10.3389/fdsfr.2022.918897)
ORCID
26.03 10
19 Effectiveness and tolerability of Poliprotect, a natural muc… (10.3389/fdsfr.2022.969831)
ORCID
26.03 10
20 A new platform for post-marketing surveillance and real-worl… (10.3389/fdsfr.2022.992359)
ORCID
26.03 10
21 Measurement error and bias in real-world oncology endpoints… (10.3389/fdsfr.2024.1423493)
ORCID
26.03 10
22 Efficacy and Safety of a Polysaccharide-Based Natural Substa… (10.3389/fdsfr.2022.844256)
ORCID
25.00 9
23 Natural language processing for automated triage and priorit… (10.3389/fdsfr.2023.1120135)
ORCID
25.00 9
24 Development and design of the BELpREG registration system fo… (10.3389/fdsfr.2023.1166963)
ORCID
25.00 9
25 Navigating a transforming landscape: the evolving role of ph… (10.3389/fdsfr.2023.1257732)
ORCID
25.00 9
26 Integrating electronic health records with other data source… (10.3389/fdsfr.2024.1428831)
ORCID
25.00 9
27 Evaluation of a natural language processing tool for extract… (10.3389/fdsfr.2022.1020943)
ORCID
23.86 8
28 Elements to assess the quality of information of case report… (10.3389/fdsfr.2023.1187888)
ORCID
23.86 8
29 Editorial: Computational methods and systems to support deci… (10.3389/fdsfr.2023.1188715)
Abstract ORCID
23.86 2
30 Achieving synchrony: bridging the gap between pharmaceutical… (10.3389/fdsfr.2024.1477516)
Abstract ORCID
23.86 2
31 An open-source platform integrating emerging data sources to… (10.3389/fdsfr.2022.1016042)
ORCID
22.58 7
32 Balancing the evidence: An update on analgesic use in rheuma… (10.3389/fdsfr.2023.1117674)
ORCID
22.58 7
33 Promising treatment biomarkers in asthma (10.3389/fdsfr.2023.1291471)
ORCID
22.58 7
34 Medical Devices Made of Substances: A New Challenge (10.3389/fdsfr.2022.952013)
ORCID
21.13 6
35 Evaluation of cardiovascular toxicity of the atezolizumab an… (10.3389/fdsfr.2023.1213771)
ORCID
21.13 6
36 External Comparator Cohort studies - clarification of termin… (10.3389/fdsfr.2023.1321894)
ORCID
21.13 6
37 Riluzole use in presence of contraindications in adults affe… (10.3389/fdsfr.2022.1041275)
ORCID
19.45 5
38 Substance-based medical devices made of natural substances:… (10.3389/fdsfr.2022.998114)
ORCID
19.45 5
39 The risk of preterm labor after COVID-19 vaccination before… (10.3389/fdsfr.2023.1235051)
ORCID
19.45 5
40 A review of the prescribing culture of anti-depressants acro… (10.3389/fdsfr.2023.1303572)
ORCID
19.45 5
41 External comparators and estimands (10.3389/fdsfr.2023.1332040)
ORCID
19.45 5
42 Application of the target trial emulation framework to exter… (10.3389/fdsfr.2024.1380568)
ORCID
19.45 5
43 Regulation 2017/745 on medical devices, two major innovation… (10.3389/fdsfr.2024.1389406)
ORCID
19.45 5
44 Datamama, bringing pregnancy research into the future: desig… (10.3389/fdsfr.2023.1187023)
ORCID
17.47 4
45 Important tool in our rare disease toolbox: hybrid retrospec… (10.3389/fdsfr.2024.1418050)
ORCID
17.47 4
46 Integrating environmental effects in the benefit-risk assess… (10.3389/fdsfr.2024.1519142)
ORCID
17.47 4
47 Leveraging real-world data for safety signal detection and r… (10.3389/fdsfr.2025.1626822)
ORCID
17.47 4
48 A national pharmacovigilance centre perspective on pandemic… (10.3389/fdsfr.2025.1644680)
ORCID
17.47 4
49 Machine learning analysis of patients’ perceptions towards g… (10.3389/fdsfr.2024.1363794)
ORCID
15.05 3
50 Editorial: Traditional and innovative approaches for signal… (10.3389/fdsfr.2024.1373689)
Abstract ORCID
15.05 1